According to Glenmark Pharmaceuticals 's latest financial reports and stock price the company's current Operating Margin is 10.87%. At the end of 2023 the company had an Operating Margin of 6.82%.
Year | Operating Margin | Change |
---|---|---|
2023 | 6.82% | -42.35% |
2022 | 11.84% | -7.46% |
2021 | 12.79% | 21.36% |
2020 | 10.54% | -21.34% |
2019 | 13.40% | 12.35% |
2018 | 11.93% | -16.1% |
2017 | 14.22% | 4.28% |
2016 | 13.63% | 49.61% |
2015 | 9.11% | -22.54% |
2014 | 11.76% | -20.9% |
2013 | 14.87% | 22.51% |
2012 | 12.14% | -25.65% |
2011 | 16.33% | 6.36% |
2010 | 15.35% | 20.82% |
2009 | 12.71% | -64.12% |
2008 | 35.41% | 22.66% |
2007 | 28.87% | 95.16% |
2006 | 14.79% | -28.87% |
2005 | 20.80% | 53.96% |
2004 | 13.51% |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.